Clinical Trial for Community-Acquired Pneumonia (CAP).

The purpose of this study is to learn about how well the Prevnar 20 vaccine (PCV20) stops invasive pneumococcal disease (a group of severe infections caused by a bacteria called Streptococcus pneumoniae), pneumococcal pneumonia (a bacterial lung disease caused by the germ Streptococcus pneumoniae), all-cause pneumonia (pneumonia caused by any germ including bacteria, a virus, or a fungus), and lower respiratory tract infection (infection of the lower airways in the lung) in people 65 years and older.

This study will use a database of people who have Medicare insurance with names and other identifying information removed. This study will include people who:

are 65 years and older,
live in one of the 50 United States or Washington DC, and
are enrolled in Medicare Fee-for-Service Parts A and B for at least 1 year.

The study uses data that is already being collected and no treatment or vaccine will be given in the study.

People that fit the description above will be followed in the Medicare database for about two years. Their information will be reviewed to see if they had vaccines for pneumonia or had certain health events, such as pneumonia or lower respiratory tract infection.

The experiences of people that received Prevnar 20 will be compared to the experiences of people that did not receive the vaccine. This will help to show how well Prevnar 20 works at stopping invasive pneumococcal disease, pneumococcal pneumonia, all-cause pneumonia, and lower respiratory tract infection.

Closest Location

To find study locations, use the location search box below.

Who may participate

Each clinical study has its own guidelines for who may participate, called eligibility criteria. These factors can include your age, sex, overall health, type and stage of disease, and personal treatment history. However, only the research study staff can determine if you qualify to enroll in the study.

Condition

Community-Acquired Pneumonia (CAP)

Sex

Male or Female

Age

65+ years

View more eligibility criteria on ClinicalTrials.gov

A Study to Learn About How Well the Prevnar 20 Vaccine Works for Pneumonia in People Who Are 65 Years and Older

Who may participate

View locations for this study

Nearest Locations found

A Study to Learn About How Well the Prevnar 20 Vaccine Works for Pneumonia in People Who Are 65 Years and Older

Who may participate

View locations for this study

Nearest Locations found

Are you a Healthcare Professional?